In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...

Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...

A daily oral GLP-1 pill can help people with obesity lose about 12% of their body weight, according to early data shared by drugmaker Eli Lilly today. The medication, called orforglipron, may be a ...

A groundbreaking daily weight loss pill could be available on the NHS next year, after its manufacturer announced plans to ...

Eli Lilly (LLY) stock plunges as Phase 3 trial data for the company's oral weight loss drug orforglipron overshadow better ...

“The results we got were as good as we can possibly achieve with an oral small molecule GLP-1," says Dr. Dan Skovronsky, ...

When it comes to compounded Ozempic and other semaglutides, Dr. Goulden adds that they are not identical to their ...

Some GPs are proving that diet and lifestyle programmes can achieve similar results to Mounjaro, Wegovy and Ozempic – without ...